FOLH1 and posterior cortical atrophy: In 3/40 (7.5%) men, a clinically significant Pca (csPCa) was found and PSMA-targeted biopsies (TPBx) vs. mpMRI-TPBx vs. SPBx diagnosed 2/3 (66.6%) vs. 2/3 (66.6%) vs. 3/3 (100%) csPCa, respectively.